Swiss drugmaker Roche has introduced an easy-to-use, molecular diagnostic platform, the cobas Liat System.

The system, designed for on-demand testing in physician clinics, pharmacies and hospital lab settings, comprises cobas Liat Analyser and a growing portfolio of assays, including cobas influenza A / B and cobas Strep A nucleic acid tests.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Using polymerase chain reaction (PCR) technology, the cobas Liat System completely automates the testing process, simplifies workflow and allows healthcare professionals to perform molecular testing in different settings and generate results within 20 minutes.

Roche Molecular Diagnostics head Paul Brown said: "This system offers significant benefits in testing time and accuracy, over current methods used to diagnose infectious disease within the physician office or urgent care clinic.

"The new system comprises of the cobas Liat Analyser and a growing portfolio of assays, including cobas influenza A / B and cobas Strep A nucleic acid tests."

"It eliminates the need for time-consuming confirmatory testing and can provide critical answers to both the healthcare professional and patient during a consultation."

See Also:

The cobas Strep A and cobas influenza A / B tests provide better sensitivity, aiding healthcare professionals to make immediate, informed treatment decisions in various testing locations.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Tests can be used in differential diagnosis of influenza A virus and influenza B virus RNA, as well as in the detection of Strep A DNA with cobas Strep A.

In addition, the cobas influenza A and B test covers more than 30 commonly found strains of influenza A and B.

The system is available in the US and Europe, while the analyser and two initial assays cobas influenza A / B and cobas Strep A, received CE Mark and FDA clearance.